These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics. Magdalinou NK; Noyce AJ; Pinto R; Lindstrom E; Holmén-Larsson J; Holtta M; Blennow K; Morris HR; Skillbäck T; Warner TT; Lees AJ; Pike I; Ward M; Zetterberg H; Gobom J Parkinsonism Relat Disord; 2017 Apr; 37():65-71. PubMed ID: 28214264 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: A meta-analysis. Ge F; Ding J; Liu Y; Lin H; Chang T Neurosci Lett; 2018 Oct; 685():35-41. PubMed ID: 30036569 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism. Constantinescu R; Rosengren L; Eriksson B; Blennow K; Axelsson M Acta Neurol Scand; 2019 Aug; 140(2):147-156. PubMed ID: 31070772 [TBL] [Abstract][Full Text] [Related]
5. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders. Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721 [TBL] [Abstract][Full Text] [Related]
6. Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms. Santaella A; Kuiperij HB; van Rumund A; Esselink RAJ; van Gool AJ; Bloem BR; Verbeek MM BMC Neurol; 2020 Jan; 20(1):26. PubMed ID: 31952511 [TBL] [Abstract][Full Text] [Related]
7. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027 [TBL] [Abstract][Full Text] [Related]
8. CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders. Herbert MK; Aerts MB; Beenes M; Norgren N; Esselink RA; Bloem BR; Kuiperij HB; Verbeek MM Front Neurol; 2015; 6():91. PubMed ID: 25999911 [TBL] [Abstract][Full Text] [Related]
9. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation. Gaetani L; Höglund K; Parnetti L; Pujol-Calderon F; Becker B; Eusebi P; Sarchielli P; Calabresi P; Di Filippo M; Zetterberg H; Blennow K Alzheimers Res Ther; 2018 Jan; 10(1):8. PubMed ID: 29370869 [TBL] [Abstract][Full Text] [Related]
10. Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis. Sako W; Murakami N; Izumi Y; Kaji R J Neurol Sci; 2015 May; 352(1-2):84-7. PubMed ID: 25868897 [TBL] [Abstract][Full Text] [Related]
11. Alpha-Synuclein Protofibrils in Cerebrospinal Fluid: A Potential Biomarker for Parkinson's Disease. von Euler Chelpin M; Söderberg L; Fälting J; Möller C; Giorgetti M; Constantinescu R; Blennow K; Zetterberg H; Höglund K J Parkinsons Dis; 2020; 10(4):1429-1442. PubMed ID: 33016895 [TBL] [Abstract][Full Text] [Related]
16. Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders. Constantinescu R; Rosengren L; Johnels B; Zetterberg H; Holmberg B Parkinsonism Relat Disord; 2010 Feb; 16(2):142-5. PubMed ID: 19647470 [TBL] [Abstract][Full Text] [Related]
17. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort. Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation. Shi M; Movius J; Dator R; Aro P; Zhao Y; Pan C; Lin X; Bammler TK; Stewart T; Zabetian CP; Peskind ER; Hu SC; Quinn JF; Galasko DR; Zhang J Mol Cell Proteomics; 2015 Mar; 14(3):544-55. PubMed ID: 25556233 [TBL] [Abstract][Full Text] [Related]